Alsin, Aviva Systems Biology, ARP57487_P050

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human Amyotrophic lateral sclerosis 2 protein and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 4 commercial research antibodies against human Amyotrophic lateral sclerosis 2 protein necoded by ALS2

The collection of antibodies was tested using HAP1 WT and ALS2 KO cells in WB (WT and KO cell lysates/30 µg protein) according to YCharOS standard protocols (see reference).

In WB (1:1000 ab dilution) ARP57487_P050 did not detected a band specific to WT cell lysate.